Jazzed Up for American Heart Association 2025 in New Orleans

Episode 19  ·  Nov 04, 2025, 06:00 PM
Headliner
Share
Subscribe

Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.

Studies discussed in today's episode:

Share
Subscribe
Next
Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition
Top episodes
COBRRA Trial Results Raise Questions About VTE Management
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest